Benactyzine_hydrochloride_DataSheet_MedChemExpress

合集下载

分子结构图

分子结构图

1、盐酸醋丁洛尔(Acebutolol Hydrochloride)化学名:N-[3-乙酰基-4-[2羟基-3-[(1-甲基乙基)氨基]丙氧基]苯基]丁酰胺盐酸盐;英文名:N-[3-Acetyl-4-[2-hydroxy-3-[(l-methylethyl)amino]Propoxy ]phenyl ]butanamide hydrochloride分子式:C18H28N2O4·HCl分子量:371.891\对丁酰胺基苯酚3\对丁酰胺基苯乙酮5\2-羟基-5-丁酰胺基苯乙酮8\2-环氧乙基甲氧基-5-丁酰胺基-苯乙酮10\醋丁洛尔2、醋谷胺铝(Aceglutamide Aluminum)化学名:N2-乙酰-L-谷氨酰胺四羟基三铝英文名:N2-Acetyl-L-glutamine aluminium complcx分子式:C35H59Al3N10O24分子量:1084.861\N-乙酰谷酰胺3、阿克他利(Actarit)化学名:4-乙酰胺基苯乙酸英文名:4-(Acetylamino)benzeneacetic acid 分子式:C10H11NO3分子量:193.211\4-氨基苯乙酸2\4-氨基苯乙酸乙酯3\4-乙酰胺基苯乙酸乙酯4\4-乙酰胺基苯乙酸,阿克他利4、阿昔洛韦(Acyclovir)化学名:2-氨基1,9-二氢-9-[(2-羟基乙氧基)甲基]-6H-嘌呤-6-酮英文名:2-amino-l,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one 分子式:C8H11N5O3分子量:225.21\鸟嘌呤3\9-(2-苯甲酰氧基乙氧基甲基) 鸟嘌呤4\阿昔洛韦阿苯达唑(Albendazole)化学名:[5-(丙硫基)-l H-2-苯并咪唑基]氨基甲酸甲酯英文名:[5-(propylthio)-l H-benzimidazol-2-yl]carbamic acid methyl ester 分子式:C12H15O2S分子量:265.341\3-氯-6-硝基乙酰苯胺3\2-硝基-5-丙硫基苯胺4\4-丙硫基-邻苯二胺5\2-氨基-5-丙硫基苯并咪唑===================================6、阿拉普拉(Alacepril)化学名:(S)-N-[l-[3-(乙酰硫基)-2-甲基丙酰]-L-脯氨酰]-L-苯丙氨酸英文名:(S)N-[l-[3-(Acetylthio)-2-methyl-l-oxopropyl]-L-prolyl]-L-phenylalanine 分子式:C20H26N2O5S分子量:406.501\l-(D-3-乙酰硫基-2-甲基丙酰)-L-脯氨酸2\L-苯丙氨酸-叔丁酯盐酸盐4\l-(D-3-乙酰硫基-2-甲基丙酰)-L-脯氨酰-L-苯丙氨酸-叔丁酯6\阿拉普拉7、阿氯芬酸(Alclofenac)化学名:3-氯-4-(2-丙烯氧)苯乙酸英文名:3-Chloro-4-(2-propenyloxy)benzeneacetic acid分子式:C11H11O3Cl分子量:2261\邻氯苯酚3\邻氯烯丙氧苯5\2-氯-4-氯甲基-烯丙氧苯6\3-氯-4-烯丙氧苯乙腈7\3-氯-4-(2-丙烯氧)苯乙酸,阿氯芬酸8、阿法骨化醇(Alfacalcidol)化学名:(1α,3β,5Z,7E)-9,10-并环胆甾-5,7,10(19)三烯-1,3-二醇英文名:(1α,3β,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3-diol分子式:C27H44O2分子量:400641\胆固醇2\ 3β-羟基-5α-胆甾烷-6-酮3\ 6-亚乙二氧基-5α-胆甾烷-3β-醇4\ 6-亚乙二氧基-胆甾烷-3 –酮4\\ 2α-溴-6-亚乙二氧基-胆甾烷-3-酮5\ 6-亚乙二氧基-l-胆甾烯-3-酮6\6-亚乙二氧基-lα ,2α–环氧胆甾烷-3-酮7\6,6-亚乙二氧基-胆甾烷-lα ,3(α,β)-双醇8\5α-胆甾烷-6-酮-lα,3(α,β)-双醇8\5α-胆甾烷-lα,3(α,β)-二乙酰氧-6-酮9\5α-胆甾烷-lα,3β-二乙酰氧-6-醇10\ lα,3β-二乙酰氧胆固醇10\\lα,3β-二乙酰氧-7-溴-胆固醇11\ lα,3β-二乙酰氧-胆甾-5,7-二烯12\ lα,3β-二乙酰氧-前维生素D313 lα,3β-二乙酰氧-维生素D314\ lα-羟维生素D39、阿明洛芬(Alminoprofen)化学名:2-[对-(2-甲基烯丙基)-氨基苯基]丙酸;α-甲基-4-[(2-甲基-2-丙烯基)氨基]苯乙酸英文名:α-Methyl-4-[(2-methyl-2-propenyl)amino]benzeneacetic acid分子式:C13H17NO2分子量:219.291\2-(对硝基苯基)丙酸甲酯2\2-(对氨基苯基)丙酸甲酯4\2-[对(2-甲基烯丙基)氨基苯基]丙酸甲酯盐酸盐5\阿明洛芬10阿普唑仑(Alprazolam)化学名:8-氯-l-甲基-6-苯基-4H-[1,2,4]三唑并[4,3-α][1,4]苯并二氮杂草英文名:8-Chloro-l-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-α][1,4]benzodiazepine 分子式:C17H13ClN4分子量:308.771\ (2-氨基础理论-氯苯基)-苯甲酮2\ 甘氨酸乙酯盐酸盐3\7-氯-5-苯基-2-氧代-2,3-二氢-l H-1,4苯并二氨杂卓5\7-氯-5-苯基-2-硫代-2,3-二氢-l H-1,4苯并二氮杂卓7\ 2-(2-乙酰肼基)-7-氯-5-苯基-3 H-1,4苯并二氮杂卓8\阿普唑仑11盐酸阿普洛尔(Alprenolo Hydrochloride)化学名:1-[(1-甲基乙基)氨基]-3-[2-(2-丙烯基)苯氧基]-2-丙醇盐酸盐英文名:1-[(1-Methylethyl)amino]-3-[2-(2-propenyl)phenoxy]-2-propanol hydrochloride 分子式:C15H23O2N·HCl分子量:285.821\ 2-丙烯苯酚2\ 表氯醇3\ 1-(邻丙烯苯氧)-2,3-环氧丙烷5\1-(邻丙烯苯氧)-2-羟-3-异丙氨-丙烷,阿普洛尔12盐酸氨溴索(Ambroxol Hydrochloride)化学名:4-[[(2-氨基-3,5-二溴苯基)甲基]氨基]环已醇盐酸盐英文名:4-[[(2-Amino-3,5-dibromophenyl)methyl]amino]cyclohexanol hydrochloride 分子式:C13H18Br2N2O·HCl分子量:414.571\ 2-氨基-3,5-二溴-N-(羟基环已基)苯甲酰胺2\ 4-(2-氨基-3,5-二溴苄胺基)-环已醇3\ 盐酸氨溴索13氨芬酸钠(Amfenac Sodium)化学名:2-氨基-3-苯甲酰苯乙酸钠二水合物英文名:2-Amino-3-benzoylbenzeneacetic acid sadinmsalt dihydrate 分子式:C15H2NO3Na·2H2O分子量:277.181\ 1-氨基-1,3-二氢吲哚-2-酮2\苯基丙酮3\1-(2-甲基苯亚乙基亚氨基)1,3-二氢吲哚-2-酮4\ 2-(2-甲基-3-苯基吲哚-7-基)乙酸乙酯5\ 2-乙酰胺基-3-苯甲酰苯乙酸乙酯6\ 7-苯甲酰1,3-二氢吲哚-2-酮7\ 2-氨基-3-苯酰苯乙酸8\氨芬酸钠14苯磺酸氨氨地平(Amlodipine Besilate)化学名:(±)-2-(2-氨基乙氧甲基)-4-(2-氯苯基)-1,4-二氢-6-甲基-3,5-吡啶二羧酸-3-乙酯-5-甲酯苯磺酸盐英文名:(±)-2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxy lic acid-3-ethyl-5-methylester Benzenesulfonate分子式:C20H25ClN2O5·C6H5SO3H分子量:567.061、2-氯苯甲醛2、乙酰乙酸甲酯3、2-(2-氯苄叉基)乙酰乙酸甲酯4、4-氯-3-氧代丁酸乙酯,氯乙酰乙酸乙酯5、2-叠氮乙醇6、2-叠氮乙氧基乙酰乙酸乙酯7、2-[(2-叠氮乙氧基)甲基]-4-(2-氯苯基)-3-乙氧羰基-5-甲氧羰基-6-甲基-1,4二氢吡啶氨氯地平15盐酸氨磺洛尔(Amosulalol Hydrochloride)化学名:5-(±)-5-[1-羟基-2-[[2-(2-甲氧基苯氧基)乙基]氨基]乙基]-2-甲基苯磺酰胺盐酸盐英文名:5-(±)-5-[1-Hydroxy-2-[[2-(2-methoxyphenoxy)ethyl]amino]ethyl]-2-methylbenzenesalfonamide hydrochloride分子式:C18H24N2O5S·HCl分子量:416.931\ 5-溴乙酰-2-甲基苯磺酰胺2\ N-[2(2-甲氧基)苯氧基乙基]苄胺3\ 5-[N-苯甲基-N-[[2-(2-甲氧基)苯氧基]乙基]氨基]乙酰-2-甲基苯磺酰胺4\ 5-[1-羟基-2-[[N-苯甲基-N-2-(2-甲氧基)苯氧基乙基]氨基]乙基]-2-甲基苯磺酰胺5\5-[1-羟基-2-[[2-(2-甲氧基苯氧基)乙基]氨基]乙基]-2-甲基苯磺酰胺盐酸盐,盐酸氨磺洛尔16阿莫西林(Amoxicillin)化学名:[2S-[2α,5α,6β(S﹡)]]-6-[[氨基(4-羟苯基)乙酰基]氨基]-3,3-二甲基-7-氧代-4-硫-1-氮杂二环[3,2,0]庚烷-2-羧酸英文名:[2S-[2α,5α,6β(S ﹡)]]-6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]h eptane-2-carboxylic acid分子式:C16H19N3O5·3H2O分子量:419.411\ ( ±)苄氧甲酰氨-4-羟苯乙酸2\ (-)苄氧甲酰氨-对羟苯乙酸3\ 6-氨基-青霉烷酸4\6-[(-)-苄氧甲酰氨-对羟基苯乙酰胺]青霉烷酸5\ 阿莫西林17氨苄西林(Ampicillin)化学名:[2S-[2α,5α,6β(S﹡)]]-6-[(氨基苯乙酰)氨基]-3,3-二甲基7-氧代-4-硫杂-1-氮杂二环[3,2,0]庚烷-2-羧酸英文名:[2S-[2α,5α,6β(S ﹡)]]-6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]heptane-2-car boxylic acid分子式:C16H19N3O4S分子量:.349.421\D(-)-α-氨基-α-苯乙酸2\ 氯甲酸苄酯3\ D(-)-苄氧基甲酰氨基-α-苯乙酸4\ 氯甲酸乙酯5\[3]和[4]的混合酸无水物6\ 6-氨基青霉烷酸7\ 6-[D(-)-α-(苄氧基甲酰氨基)苯乙酰氨]青霉烷酸8\氨苄西林18、氨力农(Amrinone)化学名:5-氨基-(3,4′-双吡啶)-6(1H)-酮英文名:5-Amino-(3,4′-bipyridin)-6(1H)-one 分子式:C10H9N3O分子量:187.201\ 4-甲基吡啶2\ 2-(4-吡啶基)-3-二甲胺基丙烯醛3\ 氰基乙酰胺4\ 3-氰基-5-(-4-吡啶基)-2(1H)-吡啶酮5\ 3-氨甲酰基-5-(-4-吡啶基)-2(1H)-吡啶酮19\阿加曲班(Argatroban)化学名:1-[5-[(氨基亚氨基甲基)氨基]-1-氧代-2[[(1,2,3,4四氢-3-甲基-8-喹啉基)磺酰]氨基]戊基]-4-甲基-2-哌啶羧酸英文名:1-[5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]a mino]pentyl]-4-methyl-2-piperidinecarboxylic acid分子式:C23H36N6O5S分子量:508.6420盐酸阿罗洛尔(Arotinolol Hydrochloride)化学名:(±)-5-[2-[[3-[(1,1-二甲基乙基)氨基]-2-羟基丙基]硫]-4-噻唑基]-2-噻吩酰胺盐酸盐英文名:(±)-5-[2-[[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropyl]thio]-4-thiazolyl]-2-thiophenecarboxa mide hydrochloride分子式:C15H21N3O2S3·HCl分子量:.408.11\ 5-乙酰基噻吩-2-羧酸2\ 5-乙酰噻吩-2-甲酰氨3\ 5-溴乙酰噻吩-2-甲酰氨4\ 二硫代氨基甲酸铵5\ 5-(2-巯基4-噻唑基)-2-噻吩甲酰氨7\ 5-[2-(3’-叔丁基氨基-2’-羟基丙基硫)-4-噻唑基]-2-噻吩甲酰氨8\ 盐酸阿罗洛尔21阿司咪唑(Astemizole)化学名:1-[(4-氟苯基)甲基]-N-[1-[2-(4-甲氧苯基)乙基]-4-哌啶基]-1H-2-苯并唑咪基胺英文名:1-[(4-Fluorophenyl)methyl] -N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl] -1H-benzimidazol-2-amine分子式:C28H31FN4O分子量:.458.251\ 1-异硫氰基-2-硝基苯酯2\ 4-氨基-1-哌啶甲酸乙酯3\ N-(2-硝基苯基)-N’-(1-乙氧甲酰-4-哌啶基)硫脲4\ N-(2-氨基苯基)-N’-(1-乙氧甲酰-4-哌啶基)硫脲5\ 2-(1-乙氧甲酰-4-哌啶基氨基)苯并咪唑6\ 4-氟苄基氯7\1-(4-氟苄基)-2-(1-乙氧甲酰-4-哌啶基氨基)苯并咪唑8\1-(4-氟苄基)-2-(4-哌啶基氨基)苯并咪唑9\甲磺酸对甲氧苯基乙酯10 阿司咪唑22阿替洛尔(Atenolol)化学名:4[2-羟基-3-[(1-甲基乙基)氨基]丙氧基]苯乙酰胺英文名:4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide 分子式:C14H22N2O3分子量:266.341\ 2-(4-环氧乙烷基甲氧苯基)-乙酰胺2\ 异丙胺3\1-对氨基甲酰甲基苯氧基-3-异丙胺基-2-丙醇,阿替洛尔23盐酸阿扎司琼(Azasetron Hydrochloride)化学名:(±)-N-1-氮杂二环[2,2,2]-3-辛基-6-氯-3,4-二氢-4-甲基-3-氧代-2H-1,4-苯并噁嗪-8-甲酰胺盐酸盐英文名:(±)-N-1-Azabicyclo[2,2,2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxazine-8-carb oxamide hydrochloride分子式:C17H20ClN3O3·HCl分子量:368.281\ 5-氯-2-羟基苯甲酸甲酯2\ 5-氯-2-羟基-3-硝基苯甲酸甲酯3\ 5-氯-2-羟基-3-氨基苯甲酸甲酯5\氯乙酰氯6\ 6-氯-4-甲基-3-氧代-3,4-二氢-2H-1,4-苯并噁嗪-8-甲酸甲酯7\ 6-氯-4-甲基-3-氧代-3,4-二氢-2H-1,4-苯并噁嗪-8-甲酸8\ 6-氯-4-甲基-3-氧代-3,4-二氢-2H-1,4-苯并噁嗪-8-甲酰氯9\ 1-氮杂-3-二环[2,2,2]辛基胺10\ 盐酸阿扎司琼24盐酸氮卓斯丁(Azelastine Hydrochloride)化学名:4-[(4-氯苯基)甲基]-2-(六氢-1-甲基-1H-4-氮杂卓基)-1(2H)-酞嗪酮盐酸盐英文名:4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinonehydroc hloride分子式:C22H25N3Cl2O分子量:418.371、2-4氯苯乙酰酰基苯甲酸2、硫酸肼3、4-(4-氯苄基)-1(2H)-酞嗪酮2-(2-氯乙基)-N-甲基吡咯烷盐酸盐5、4-(4-氯苄基)-2[N-甲基全氢化氮杂卓基-(4)-]-1(2H)-酞嗪酮6、4-(4-氯苄基)-2-[N-甲基全氢化氮杂卓基-(4)-]-1-(2H)酞嗪酮盐酸盐,盐酸氮卓斯丁25奥(Azulene)化学名:环戊二烯并环庚三烯英文名:Cyclopentacycloheptene 分子式:C10H8分子量:128.161\ 1,6-己二酸2\ 6-羰基-壬二酸3\ 5-(2-乙酰基-1-环戊烯基)-戊酸4\ 2,3,5,6,7,8-六氢-1H–奥-4-酮5\ 八氢,奥-4-酮6\ 十氢奥-4-醇7\奥26盐酸巴氨西林(Bacampicillin Hydrochloride)化学名:[2S-[2α,5α,6β(S﹡)]]-6-[(氨基苯基乙酰)氨基]-3,3-二甲基-7-氧代4-硫杂-1-氮杂二环[3,2,0]庚烷-2-羧酸-1-[(乙氧羰基)氧基]乙酯盐酸盐英文名:[2S-[2α,5α,6β(S﹡)]]-6-[(Aminophenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3,2,0]heptane-2-car boxylic acid 1-[(ethoxycarbonyl)oxy]ethyl ester hydrochloride分子式:C21H27N3O7S·HCl分子量:502.001\ 碳酸-1-氯乙酯乙酯3\碳酸-1-溴乙酯乙酯4\ 6-[(氨基苯基乙酰)氨基]-3,3-二甲基7-氧代号-硫杂志-氮杂二环[3,2,0]庚烷-2-羧酸5\ 乙酰乙酸甲酯6\ 6-[2-(甲氧羰基)-1-甲基乙烯基氨基苯基(乙酰)氨基]-3,3-二甲基-7-氧代-4-硫杂-1-氮杂二环[3,2,0]庚烷-2-羧酸7\ 盐酸巴氨西林27巴氯芬(Baclofen)化学名:β-(氨甲基)-4-氯苯丙酸英文名:β-(Aminomethyl)-4-chlorobenzenepropanoic acid分子式:C10H12ClNO2分子量:213.661\ 对氯肉桂酸乙酯2\ 硝基甲烷3\ β-硝甲基4-氯苯丙酸乙酯4\ 4-(对氯苯)-2-吡咯烷酮28苄达酸(Bendazac)化学名:[(1-苄基-1H-3-吲唑基)氧基]乙酸英文名:[(1-Phenylmethyl) -1H-indazol-3-yl]-oxy]-acetic acid 分子式:C16H14H2O3分子量:282.301\ 1-苄基-1H-3-吲唑醇钠2\ 氯乙晴3\ 1-苄-3-吲唑-氧乙腈4\ 苄达酸29盐酸苄丝肼(Benserazide Hydrochloride)化学名:DL-丝氨酸-2-[(2,3,4-三羟苯基)甲基]酰肼盐酸盐英文名:DL-Serine-2-[(2,3,4-trihydroxyphenyl)methyl]-hydrazidc hydrochloride 分子式:C10H15N3O5·HCL分子量:293.711\ DL-丝氨酰肼盐酸盐2\ 2,3,4-三羟苯甲醛3\ DL-丝氨酰-2-(2,3,4-三羟基亚苄基)酰肼盐酸盐4\ 盐酸苄丝肼30苯溴马隆(Benzbromarone)化学名:(3,5-二溴-4-羟基苯基)-(2-乙基-3-苯并呋喃)-甲酮英文名:(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)methanone 分子式:C17H12Br2O3分子量:424.091\ 水杨醛2\ 一氯丙酮3\2-乙酰苯并呋喃4\ 水合肼5\ 2-乙基苯并呋喃6\ 对甲氧基苯甲酰氯7\ 2-乙基3-茴香酰-苯井呋喃8\ 吡啶盐酸盐9\2-乙基地-3-(对-羟-苯甲酰)-苯并呋喃10\ 苯溴马隆31二丙酸倍他米松(Betamethasone Dipropionate)化学名:(11β,16β)-9-氟-11,17,21-三羟-16-甲基-孕甾-1,4-二烯-3,20-双酮-17,21-二丙酸酯英文名:(11β,16β)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate分子式:C28H37FO7分子量:504.591\ 9α-氟-11β,17α,21-三羟基-16β-甲基-5α-孕甾烷-3,20-二酮-21-乙酸酯3\ 11β三甲基硅烷氧基-9α-氟-17α,21-二羟基-16β-甲基-5α-孕甾烷-3,20-二酮-21-乙酸酯4\ 11β三甲基硅烷氧基-9α-氟-17α,21-二羟基-16β-甲基-5α-孕甾烷-3,20-二酮5\ 丙酸酐6\对甲苯磺酸7\11β三甲基硅烷氧基-9α-氟-17α,21-二羟基-16β-甲基-5α-孕甾烷-3,20-二酮-17,21-二丙酸酯8\ 2,3-二氯-5,6-二腈-苯醌(DDQ)9\ 11β三甲基硅烷氧-17α,21-二羟基-基-9α-氟-16β-甲基孕甾-1,4-二烯-3,20-二酮-17,21-二丙酸酯10\ 9α-氟-11β,17α,21-三羟基-16β-甲基孕甾-1,4-二烯-3,20-二酮-17,21-二丙酸酯, 二丙酸倍他米松32倍他米松磷酸钠(Betamethasone Sodium phosphate)化学名:9α-氟-11β,17α,21-三羟基-16β-甲基孕甾-1,4-二烯3,20-二酮-21-(二氢磷酸酯)二钠盐英文名:(11β,16β)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione-21-(dihydrogenph osphate)disodium salt分子式:C22H29FNaO8P分子量:494.431\ 3α-乙酰氧基-16-孕甾烯-11,20-二酮3\ 3α-乙酰氧基-16α,17α-亚甲偶氮孕甾-11,20-二酮4\ 3α-乙酰氧基-16-甲基-16-孕甾烯- 11,20-二酮6\ 16α,17α-环氧-3α-羟基-16β-甲基孕甾-11,20-二酮7\ 3α,17α-二羟基-16β-甲基孕甾- 11,20-二酮8\ 21-溴-3α,17α-二羟基-16β-甲基孕甾- 11,20-二酮10\ 3α,17α-21-三羟基-16β-甲基孕甾- 11,20-二酮-21-乙酸酯11\N-溴琥珀酰亚胺12\ 17α,21-二羟基-16β-甲基孕甾- 3,11,20-三酮-21-乙酸酯13\ 4-溴-17α,21-二羟基-16β-甲基孕甾-3, 11,20-三酮-21乙酸酯14\ 盐酸氨基脲15\ 17α,21-二羟基-16β-甲基-4-孕甾烯- 3,11,20-三酮-21-乙酸酯的-3-缩氨基脲16\ 17α,21-二羟基-16β-甲基-4-孕甾烯- 3,11,20-三酮-21-乙酸酯17\ 17α,21-二羟基-16β-甲基-4-孕甾烯- 3,11,20-三酮-21-乙酸酯的-3,20-二缩氨基脲19\11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3,,20-二酮的-3,20-二缩氨基脲20\ 11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3,20-二酮21\ 乙酐22\ 11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3,,20-二酮-21-乙酸酯23\ 甲磺酰氯24\ 17α,21-三羟基-16β-甲基-4,9(11)-孕甾二烯- 3,,20-二酮-21-乙酸酯25\ 9α-溴-11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3, 20-二酮-21-乙酸酯27\ 9β,11β-环氧- 17α,21-二羟基-16β-甲基-4-孕甾烯- 3, 20-二酮-21-乙酸酯28\ 9α-氟-11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3, 20-二酮-21-乙酸酯30\9α-氟-11β,17α,21-三羟基-16β-甲基-1,4-孕甾二烯- 3, 20-二酮-21-乙酸酯31\倍他米松32\ 9α-氟-11β,17α,21-三羟基-16β-甲基-4-孕甾烯- 3, 20-二酮-21-甲磺酸酯33\ 9α-氟-16β-甲基-11β,17α–二羟基- 3, 20-二氧代-21-碘-1,4-孕甾二烯34\ 9α-氟-16β-甲基11β,17α,21-三羟基- 3, 20-二氧代1,4-孕甾二烯-21-磷酸二氢酯35\倍他米松磷酸钠33\盐酸贝凡洛尔(Bevantolol Hydrochloride)化学名:1-[[2-(3,4-二甲氧基苯基)乙基]胺基]-3-(3-甲苯氧基)-2-丙醇盐酸盐英文名:1-[[2-(3,4-Dimethoxyphenyl)ethyl]amino]-3-(3-methylphenoxy)-2-propanol hydrochloride分子式:C20H27NO4·HCl分子量:381.901\ 3-甲基苯酚2\ 氯甲基环氧乙烷3\ 3-甲苯氧基环氧乙烷4\2-(3,4-二甲氧苯基)乙胺5\盐酸贝凡洛尔34\盐酸溴己新(Bromhexine Hydrochloride)化学名:2-氨基-3,5二溴-N-环已基- N-甲基苯甲铵盐酸盐英文名:2-Amino-3,5-dibromo-N-cyclohexyl-N-methylbenzenemethanamine hydrochloride 分子式:C14H21N2Br2Cl分子量:412.631\ 2-硝基溴苄2\ N-甲基环已胺3\ N-(2-硝基苄)- N-甲基环已胺5\ N-(2-氨基苄)- N-甲基环已胺6\盐酸溴已新35\溴哌利多(Bromperidol)化学名:4[4-(4-溴苯基)-4羟基-1-哌啶基]-1-(4-氟苯基)-1-丁酮英文名:4[4-(4-Bromophenyl)-4-hydroxy-1-piperidinyl]-1-(-4-fluorophenyl)-1-butanone 分子式:C21H23BrFNO2分子量:420.331\4-溴苯基溴化镁2\ 1-(乙氧羰基)-4-氧代哌啶3\ 1-(乙氧羰基)-4-羟基-4-(4-溴苯基)哌啶4\ 4-羟基-4-(4-溴苯基)哌啶5\ 1-(4-氯丁酰)-4氟苯6\ 溴哌利多36\溴替唑仑(Brotizolam)化学名:2-溴-4-(2-氯苯基)-9-甲基-6H-噻嗯并-[3,2-f ]-[1,2,4]-三唑并-[4,3-α]-[1,4]-二氮杂卓英文名:2-Bromo-4-(2-chlorophenyl)-9-methyl-6H-thieno-[3,2-f ]-[1,2,4]-triazolo-[4,3-α]-[1,4]-diazepine 分子式:C22H19Br分子量:363.311\ 7-溴-5-(2-氯苯基)-1,3-二氢噻嗯-[2,3-e]-1,4-二氮杂卓-2-酮2\ 7-溴-5-(2-氯苯基)-1,3-二氢-[2,3-e]-噻嗯-1,4-二氮杂卓-2-硫酮3\ 7-溴-5-(2-氯苯基)-2-肼基-1,3-二氢-[2,3-e]- 噻嗯-1,4-二氮杂卓4\ 正乙酸二乙酯5\溴替唑仑37富马酸溴长春胺(Brovincamine Fumarate)化学名:(3α,14β,16α)-11-溴-14,15-二氢-14-羟基象牙烯宁-14-羧酸甲酯富马酸盐英文名:(3α,14β,16α)-11-Bromo-14-15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid methylester fumarate分子式:C21H25BrN2O3·C4H4O4分子量:549.351\ (3α,14β,16α)-长春胺2\溴长春胺38布地奈德(Budesonide)化学名:(11β,16α)-16,17-[亚丁基双(氧)]-11,21-二羟基孕甾-1,4-二烯-3-20-二酮英文名:(11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione分子式:C25H34O6分子量:430.551\ 16α-羟基泼尼松龙2\布地奈德39\盐酸布那唑嗪(Bunazosin Hydrochloride)化学名:1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)-6-氢-4-(1-氧代丁基)-1H-1,4-二氮卓盐酸盐英文名:1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)hexahydro-4-(1-oxobutyl)-1H-1,4-diazepinehydrochlo ride分子式:C19H27N5O3·HCl分子量:409.931\ 2-氯-4-氨基-6,7-二甲氧基喹唑啉2\ N-甲酰高哌嗪3\ 2-(N-甲酰高哌嗪基)-4-氨基-6,7二甲氧基喹唑啉4\ 2-高哌嗪基-4-氨基-6,7-二甲氧基喹唑啉盐酸盐5\ n-丁酰氯6\ 盐酸布那唑嗪40盐酸布尼洛尔(Bunitrolol Hydrochloride)化学名:2-[3-[(1,1-二甲基乙基)氨基]-2羟基丙氧基]苄腈盐酸盐英文名:2-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]benzonitrile hydrochloride 分子式:C14H20ON2O2·HCl分子量:248.81\ 2-环氧乙烷甲氧基-苄腈3\盐酸布尼洛尔。

二乙氨基羟苯甲酰基苯甲酸己酯-安全技术说明书MSDS

二乙氨基羟苯甲酰基苯甲酸己酯-安全技术说明书MSDS

第一部分化学品及企业标识化学品中文名:二乙氨基羟苯甲酰基苯甲酸己酯化学品英文名:Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexyl esterCAS No.:302776-68-7分子式:C24H31NO4产品推荐及限制用途:工业及科研用途。

第二部分危险性概述紧急情况概述可能对水生生物造成长期持续有害影响。

GHS危险性类别危害水生环境——长期危险类别 4标签要素:象形图:警示词:危险危险性说明:H413 可能对水生生物造成长期持续有害影响●预防措施:—— P273 避免释放到环境中。

●事故响应:—— P301+P310 如误吞咽:立即呼叫解毒中心/医生—— P330 漱口。

—— P305+P351+P338 如进入眼睛:用水小心冲洗几分钟。

如戴隐形眼镜并可方便地取出,取出隐形眼镜。

继续冲洗。

—— P310 立即呼叫解毒中心/医生●安全储存:—— P403+P233 存放在通风良好的地方。

保持容器密闭。

—— P405 存放处须加锁。

●废弃处置:—— P501 按当地法规处置内装物/容器。

物理和化学危险:无资料。

健康危害:无资料。

环境危害:可能对水生生物造成长期持续有害影响。

第三部分成分/组成信息√物质混合物第四部分急救措施急救:吸入:如果吸入,请将患者移到新鲜空气处。

皮肤接触:脱去污染的衣着,用肥皂水和清水彻底冲洗皮肤。

如有4不适感,就医。

眼晴接触:分开眼睑,用流动清水或生理盐水冲洗。

如有不适感,就医。

食入:饮水,禁止催吐。

如有不适感,就医。

对保护施救者的忠告:将患者转移到安全的场所。

咨询医生。

出示此化学品安全技术说明书给到现场的医生看。

对医生的特别提示:无资料。

第五部分消防措施灭火剂:用水雾、干粉、泡沫或二氧化碳灭火剂灭火。

避免使用直流水灭火,直流水可能导致可燃性液体的飞溅,使火势扩散。

特别危险性:无资料。

灭火注意事项及防护措施:消防人员须佩戴携气式呼吸器,穿全身消防服,在上风向灭火。

七叶苷(倍半水)化学品安全技术说明书

七叶苷(倍半水)化学品安全技术说明书

化学品安全技术说明书公司地址:上海化学工业区奉贤分区银工路28号E栋楼客服热线:400-133-2688 1 化学品及企业标识1.1 产品标识符化学品俗名或商品名:七叶苷(倍半水)CAS No.:66778-17-4别名:七叶苷;七叶苷水合物;七叶苷(倍半水);马栗树皮苷;1.2 鉴别的其他方法无数据资料1.3 有关的确定了的物质或混合物的用途和建议不适合的用途仅供科研用途,不作为药物、家庭备用药或其它用途。

2 危险性概述2.1 GHS分类根据全球化学品统一分类和标签制度(GHS)的规定,不是危险物质或混合物。

2.2 GHS 标记要素,包括预防性的陈述2.3 其它危害物-无3 成分/组成信息3.1 物质分子式 - C15H18O10分子量 - 367.314 急救措施4.1 必要的急救措施描述一般的建议无数据资料如果吸入如果吸入,请将患者移到新鲜空气处。

如呼吸停止,进行人工呼吸。

在皮肤接触的情况下用肥皂和大量的水冲洗。

在眼睛接触的情况下用水冲洗眼睛作为预防措施。

如果误服切勿给失去知觉者通过口喂任何东西。

用水漱口。

4.2 最重要的症状和影响,急性的和滞后的虚弱,呕吐,腹泻4.3 及时的医疗处理和所需的特殊处理的说明和指示无数据资料5 消防措施5.1 灭火介质火灾特征无数据资料灭火方法及灭火剂用水雾,抗乙醇泡沫,干粉或二氧化碳灭火。

5.2 源于此物质或混合物的特别的危害无数据资料5.3 救火人员的预防如必要的话,戴自给式呼吸器去救火。

5.4 进一步的信息无数据资料6 泄露应急处理6.1 人员的预防,防护设备和紧急处理程序避免粉尘生成。

避免吸入蒸气、烟雾或气体。

6.2 环境预防措施不要让产品进入下水道。

6.3 抑制和清除溢出物的方法和材料扫掉和铲掉。

放入合适的封闭的容器中待处理。

7 安全操作与储存7.1 安全操作的注意事项在有粉尘生成的地方,提供合适的排风设备。

7.2 安全储存的条件,包括任何不兼容性贮存在阴凉处。

伯乐生化质控靶值表310

伯乐生化质控靶值表310
oset0europe15胆碱酯酶umollsec8426674101315252378胆碱酯酶umollsec985789118370296443creatinekinasecknacactivatedeuropeasia5肌酸激酶umollsec215172258704563845creatinekinaseckrosalkiothermodied5肌酸激酶umollsec212169254713570855creatinealkalinepicratekineticcartridgecrsumoll188150225510408612creatinealkalinepicratekineticmodularcre3creatineenzymaticcredigoxinimmunoturbidimetric地高辛nmoll107339271407gammaglutamyltransferaseggtszasz5谷氨酰转肽酶umollsec0927249gammaglutamyltransferaseggtszaszifcc20025谷氨酰转肽酶umollsec1070853128257206309glucoseglucoseoxidaseoxygenconsumptionglu3葡萄糖mmoll462148glucosehexokinase0glu葡萄糖mmoll493394591155ironferrozinenodeproteinizationumoll428118lactatelacticacidenzymatic乳酸umolllactatedehydrogenaseldhlactatepyruvate5乳酸脱氢酶umollsec234281281502401602lactatedehydrogenaseldhlactatepyruvateifcc20025乳酸脱氢酶umollsec291611489733lipasecolorimetriclip5脂肪酶umollsec0590154magnesiumcalmagitemmoll0830163phenobarbitalimmunoturbidimetric苯巴比妥umollphenytoinimmunoturbidimetricumoll423865phosphorusphosphomolybdateuvcartridgepo4mmoll115240p

加州65有害物质清单2013中文版

加州65有害物质清单2013中文版

Listing Mechanism SQE SQE SQE SQE SQE AB FR
FR FR
CAS No. --15972-60-8 --309-00-2 302-79-4 107-05-1 28981-97-7 645-05-6 665-66-7 39831-55-5 117-79-3 60-09-3 97-56-3 92-67-1 81-49-2 6109-97-3 153-78-6 125-84-8 --82-28-0 712-68-5 119-34-6 54-62-6 19774-82-4 33089-61-1 61-82-5 14028-44-5 51264-14-3 994-05-8 ----63-05-8 --62-53-3 142-04-1
cancer cancer cancer developmental cancer developmental cancer cancer cancer developmental, male cancer cancer developmental cancer
AB SQE AB
FR
SQE FR SQE AB AB
AB
26148-68-5 75-07-0 60-35-5 59-66-5 34256-82-1 546-88-3 53-96-3 62476-59-9 79-06-1 79-06-1 107-13-1 50-76-0 50-76-0 3688-53-7
1-Jan-90 2 1-Apr-88 90 (inhalation) 1-Jan-90 10 20-Aug-99 1-Jan-89 1-Apr-90 1-Jul-87 0.2 1-Jan-90 1-Jan-90 0.2 25-Feb-11 1-Jul-87 1-Oct-89 1-Oct-92 1-Jul-87

反应釜系统验证方案

反应釜系统验证方案

类别:设备验证方案部门:生产部反应釜验证方案方案号:VF-01-U131-2011A01-003验证时间: 2011年11月XX日2011年11月XX日验证地点:无锡凯利药业多肽药物车间合成间无锡市凯利药业有限公司目录1.验证方案起草批准 (2)1.1验证小组成员及职责 (2)1.2验证方案起草 (2)1.3验证方案批准 (2)2.验证目的 (3)3.验证内容 (3)3.1预确认(DQ) (3)3.2回顾性安装确认(IQ) (4)3.3运行确认(OQ) (6)3.4反应釜系统性能确认(PQ); (7)4.验证结果及分析评价 (8)5.再验证周期 (8)本公司依替巴肽原料药的合成使用的根据工艺要求和使用的物料性质选择一台30L双层玻璃(S212-30L)反应釜、一台高低温一体机(GDSZ-30/40)和一台循环水真空泵(SHZ-D),安装于生产防爆车间合成岗位,该设备耐腐蚀,耐有机溶剂,结构简单,操作方便,专用于依替巴肽原料药的原料合成反应。

1.验证方案起草批准1.1验证小组成员及职责部门验证人员职务验证分工生产部康国伟经理/组长负责起草验证方案、组织协调验证姚程成合成员负责验证反应釜系统验证及撰写验证报告质管部卢明星质量管理员负责文件核查及现场监督设备工程部许建经理保证设备正常运转1.2验证方案起草起草部门签名日期生产部年月日1.3验证方案批准批准人签名日期生产部年月日2.验证目的按照GMP的要求,需要对该设备进行安装确认、运行和性能确认,通过该设备的验证,检查设备的规格、型号是否符合设计要求,设备的安装质量是否符合该设备正常运行的基本条件,辅助设施的布置是否合理、可靠、安全等,设备的生产能力是否既能满足生产需要,又能符合工艺要求。

3.验证内容3.1预确认(DQ)3.1.1供应商的资格和服务反应釜/高低温一体机地址/电话循环水真空泵地址/电话确认项目确认结果生产此类设备的经验、水平D1、D2级低中压压力容器制造能否保证在安装、培训和试车方面给予全面支持培训与否技术文件(技术图样、设计资格证明)等是否完整,符合国家标准单项结论:_________________________________________________________检测人:日期:年月日复核人:日期:年月日3.1.2设备使用材质和结构确 认 项 目符合情况材质要求不与物料或清洗消毒剂反应 材质中无组分溶出或吸收组分 不脱落材料颗粒 便于操作,物料能全部排出便于拆卸、维护设备零件、计量仪表有较高的通用性和标准化程度润滑密封装置合理、安全,不会对药物造成污染单项结论:_________________________________________________________检测人: 日期: 年 月 日 复核人: 日期: 年 月 日3.1.3 需要的性能参数,能达到要求压力、温度该设备安装于本公司车间防爆合成岗位,该设备结构简单,操作方便,物料能全部排出,运行过程中噪声不会使人感到不适,且与采用的厂房、设施匹配。

雅D-苯甘氨酸甲酯盐酸盐制备及纯化工艺研究-化学工程与技术专业毕业论文

雅D-苯甘氨酸甲酯盐酸盐制备及纯化工艺研究-化学工程与技术专业毕业论文

D-苯甘氨酸甲酯盐酸盐制备及纯化工艺研究-化学工程与技术专业毕业论文河北科技大学硕士学位论文IIAbstract=========;暑=;昌昌============;==≈==;穹皇=========;号皇;=兰===昌==暑=======置==宣号=== =:AbstractD。

phenylglycine methyl ester hydrochloride,a type of white crystalline powder and important p harmaceutical i ntermediate,iS a n e ssential active side chain f or t he production of cephalexin,cefaclor,and other IMactam antibiotics.In this paper,the synthesis and crystallization purification technique of D-phenylglycine methyl ester hydrochloride is systematically studied.The study on the synthesis of D—phenylglycine methyl ester hydrochloride.A preliminary synthetic route of D·phenylglycine methyl ester hydrochloride was designed,and sulfoxide chloride method was determinedexperimentally as a preferred syntheticroute.In the experiment,the synthesis technique conditions such as thesequence of adding reagents,the ratio of reagents,the reaction temperature,the reflux time,and the adding rate of sulfoxide chloride were investigated and optimized.After the completion of the reaction,the vacuum azeotropic distillation and cooling crystallization with the temperature controlling should be done to the mother liquor.Finally through the post‘pmcessing,we can get.t11e crystal product of D—phenylglycine methyl ester hydrochloride.The purity of the product detected by using HPLC is more than 98.5%.with the yield more than 96%.The study on the thermodynamics of D-phenylglycine methyl ester hydrochloridecrystallization.Thesolubility and supersolubility of D—phenylglycine methylesterhydrochloride in six pure solvents(water,methanol,ethanol,acetone,ethyl acetate,and toluene)as well as in two kinds of binary mixed solvents with different compositions (methanol—ethyl acetate and methanol—toluene)were measured under the conditions of atmospheric pmssure and the temperature range of 283.1 5K-333.1 5K by using Laser Dynamics Method.Then the Apelblat equation,CNIBS/Redlich.Kister equation.and NRTL equation were used to correlate the data of solubility,and it showeda satisfactoryresult.Finally,thermodynamic properties in the dissolution process wereanalyzed systematically,and changes of the free energy of standard molar enthalpy,Standard molar entropy and Standard Gibbs of D-phenylglycine methyl ester hydrochloride in the dissolution process in different solvents were calculated.The study on thermodynamics of crystallization of D—phenylglycine methyl ester hydrochloride provides a theoretical reference and data base forthe development of its crystallizationtechnique.IIlThe crystallization kinetics of D.phenylglycine methyl ester hydrochloride was studied by batch dynamic methods.Samples of different times were measuredunderdifferent processing conditions.Then the CSD Was analyzedby laserCrystallization dynamic models of D.phenylglycine methyl ester granulometer.hydrochloride were established based on the mass balance equation and population balance equation.ARertransformation of moments on theexperimental data,the mathematical models for crystal growth rate and secondary nucleation rate were obtained,and the operating parameterswhich affected the crystallographicprogress were analyzed.The study on the crystallizationtechnique of D-phenylglycine methyl esterhydrochloride.The crystallization technique of D..phenylglycinemethyl ester hydrochloride Was studied on the basis of crystallization thermodynamics and dynamics.The influence of crystallization method and process conditions on the quality and vield of product Wasstudied.A new crystallization and purification technique ofD-phenylglycinemethyl ester hydrochloride Was developed.The crystals produced by this new technique is of high purity,high yield,and good color level(1evel 1),and their particle size increaSed anduniformed obviously.With stablequality of the product,low production COst aS wellas easy operation control,this technique has applied for China National invention patent.Andthousand tons has been realized.the industrialization of the annualoutput ofKey words D-phenylglycine methyl ester hydrochloride;Synthesis technique;Crystallization thermodynamics;Crystallization kinetics;The crystallizationtechniqueIV物理量名称及符号表物理量名称及符号表4一Apelblat方程参数;尸一压强;彳一晶体外表积:尸一系统搅拌强度量;40一指数因子;Qi-粒数密度;B—Apelblat方程参数:B一为生函数;Qi-引入结晶器的晶浆流量;矿一总成核速率;Q一引出结晶器的晶浆流量;啷一均相成核速率;,.一晶核半径;召s一二次成核速率;R一气体常量;C--Apelblat方程参数;R2一相关指数;C一溶液主体浓度;仅,,一与溶剂有关的非随机参数;Ci一溶液界面浓度;Gl,一NRTL模型参数;C。

tetracycline hydrochloride结构式名

tetracycline hydrochloride结构式名

tetracycline hydrochloride结构式名Tetracycline Hydrochloride: A Breakthrough Antibiotic that Revolutionized MedicineIntroduction:Tetracycline hydrochloride is a potent antibiotic that has played a significant role in the treatment of various infectious diseases since its discovery in the mid-20th century. In this article, we will explore the structural features of tetracycline hydrochloride and delve into its mechanism of action, clinical uses, and potential side effects. Join us on this journey as we uncover the impact this compound has had on the field of medicine.Structural Features and Composition:Tetracycline hydrochloride, also known by its chemical formula C22H24N2O8·HCl, is a semisynthetic derivative of a natural antibiotic produced by Streptomyces bacteria. The compound consists of four fused rings, referred to as rings A, B, C, and D, which are responsible for its antibacterial activity. The presence of various functional groups, such as dimethylamine, hydroxyl, and carbonyl moieties, confers different properties to tetracycline hydrochloride.Mechanism of Action:Tetracycline hydrochloride exerts its antimicrobial effect by inhibiting bacterial protein synthesis. It does so by binding reversibly to the 30S ribosomal subunit in susceptible bacterial cells, preventing the attachment of aminoacyl-tRNA to the messenger RNA-ribosome complex. Additionally, it interferes with the proofreading mechanism of the ribosome, leading to the incorporation of incorrect amino acids into the growing protein chain. This disruption of protein synthesis effectively inhibits bacterial growth and replication.Clinical Uses:Tetracycline hydrochloride has been widely employed in the treatment of various infectious diseases, including respiratory tract infections, urinary tract infections, sexually transmitted infections, and skin and soft tissue infections. Its broad-spectrum activity against both gram-positive and gram-negative bacteria has made it a valuable tool in combating bacterial infections, particularly in settings where other antibiotics are ineffective or contraindicated.Emerging Applications:Beyond its traditional uses, tetracycline hydrochloride has shown promise in a range of non-infectious conditions. Research suggests its potential in treating variousinflammatory disorders, such as rheumatoid arthritis and ocular inflammatory diseases. Additionally, studies have explored its potential role in the treatment of certain cancers, as it possesses anti-tumor properties. However, further research is necessary to fully understand and harness its therapeutic potential in these novel areas.Side Effects and Precautions:While tetracycline hydrochloride has proven to be an invaluable treatment option, it is not without its side effects. Common adverse reactions include gastrointestinal disturbances, such as nausea, vomiting, and diarrhea. Photosensitivity reactions can also occur, necessitating caution when exposed to sunlight or ultraviolet radiation. Long-term use of tetracycline hydrochloride can result in discoloration of teeth and bones, making it unsuitable for use in pregnant women and children under the age of eight.Conclusion:Tetracycline hydrochloride has emerged as a game-changer in the field of antibiotics, revolutionizing the treatment of infectious diseases. Its unique structural features, mechanism of action, and broad-spectrum activity have made it a cornerstone in the fight against bacterial infections.Moreover, ongoing research suggests potential applications in inflammatory disorders and cancer treatment. While side effects must be considered, the benefits of tetracycline hydrochloride far outweigh the risks when used judiciously. Continued exploration of this remarkable compound promises to uncover new therapeutic avenues and improve the health outcomes of countless patients worldwide.。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Inhibitors, Agonists, Screening Libraries
Data Sheet
BIOLOGICAL ACTIVITY:
Benactyzine hydrochloride is a butyrylcholinesterase (BChE ) inhibitor with a K i of 0.010 mM.
IC50 & Target: Ki: 0.010 mM (BChE)[1]
In Vitro: Benactyzine hydrochloride and drofenine are widely used anticholinergic drugs which are also competitive inhibitors of BChE with K i values of 0.010±0.001 and 0.003±0.000 mM, respectively. Results indicate that the inhibition of BChE by Benactyzine
hydrochloride is pure or partial competitive. Pure competitive inhibition can be distinguished from partial competitive inhibition by plotting v vs [Benactyzine] at a fixed [BTCh][1].
In Vivo: Benactyzine hydrochloride (1 mg/kg) does not influence the attention response. Benactyzine hydrochloride increases the duration of the exploratory–motor reaction, but slightly diminishes the salivation elicited by acetylcholine. There is no blocking effect of Benactyzine hydrochloride and promazine on the EEG–seizure activity elicited by acetylcholine, and almost no inhibitory effect on emotional reactions. Emotional reactions are blocked by high doses of imipramine and promazine, but not by Benactyzine
hydrochloride. The data indicates that imipramine, promazine and Benactyzine hydrochloride influence the autonomic effects of serotonin in different ways. Promazine, and especially Benactyzine hydrochloride, inhibit and shorten the period of salivation elicited by the intra–amygdaloid injection of serotonin [2].
PROTOCOL (Extracted from published papers and Only for reference)
Kinase Assay:[1]Butyrylcholinesterase activity is measured spectrophotometrically with spectrophotometer using butyrylthiocholine iodide (BTCh) as substrate. In the kinetic studies, initial velocities are measured at 37°C by using 0.25 mM
5,5’–dithio–bis(2–nitrobenzoic acid) (DTNB) in 5 mM 3–(N–morpholino)propanesulfonic acid (MOPS) buffer, pH 7.5, and appropriate concentrations of Benactyzine hydrochloride and drofenine solutions prepared in water, as a function of BTCh concentration from 0.25 to 5.0 mM BTCh in 0.5 mL final volume of assay mixture (0.5 mL assay mixture contains 1.56 mg purified enzyme). Assays are carried out in duplicate and activities are measured for up to 90 s [1].
Animal Administration:[2]Experiments are carried out in 36 cats of both sexes weighing 1.8 to 4 kg in a free–behavior situation. The experiments are carried out in the following order: after the first micro–injection of acetylcholine and/or serotonin and/or
noradrenaline (200 μg) into the amygdala the changes in the behavior, autonomic reactions and EEG are recorded for a period of 10min and then followed by intramuscular injections of imipramine and/or Benactyzine hydrochloride and/or promazine and/or saline (in control experiments). The second micro–injection of neurohormones (200 μg) into the amygdala is performed in 45 rain after the intramuscular injection of drugs and/or saline, and the effect is compared with the previous one, induced by the first micro–injection [2]
. Product Name:
Benactyzine hydrochloride Cat. No.:
HY-B1542A CAS No.:
57-37-4Molecular Formula:
C20H26ClNO3Molecular Weight:
363.88Target:
AChE Pathway:
Neuronal Signaling Solubility:
DMSO: 150 mg/mL
References:
[1]. Bodur E, et al. Inhibition effects of benactyzine and drofenine on human serum butyrylcholinesterase. Arch Biochem Biophys. 2001 Feb 1;386(1):25–9.
[2]. Allikmets LH, et al. Dissimilar influences of imipramine, benactyzine and promazine on effects of micro–injections ofnoradrenaline, acetylcholine and serotonin into the amygdala in the cat. Psychopharmacologia. 1969;15(5):392–403.
Caution: Product has not been fully validated for medical applications. For research use only.
Tel: 609-228-6898 Fax: 609-228-5909 E-mail: tech@
Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA。

相关文档
最新文档